Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_assertion type Assertion NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_head.
- NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_assertion description "[These regions harbor established oncogenes and tumor suppressors, including CCND1 (cyclin D1), MET (hepatocyte growth factor receptor), CDKN2A (cyclin-dependent kinase inhibitor 2A) and CDKN2B (cyclin-dependent kinase inhibitor 2B), as well as many other genes not previously reported to be involved in liver carcinogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_provenance.
- NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_assertion evidence source_evidence_literature NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_provenance.
- NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_assertion SIO_000772 23505090 NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_provenance.
- NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_assertion wasDerivedFrom befree-2016 NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_provenance.
- NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_assertion wasGeneratedBy ECO_0000203 NP1061332.RAH8kVzsctsri4ToV7bXN1tjLKA3gu_QKtj3_zkOZEnAI130_provenance.